CY1398A - Pharmaceutical compositions containing non-steroidal anti-inflammatory agents - Google Patents
Pharmaceutical compositions containing non-steroidal anti-inflammatory agentsInfo
- Publication number
- CY1398A CY1398A CY139882A CY139882A CY1398A CY 1398 A CY1398 A CY 1398A CY 139882 A CY139882 A CY 139882A CY 139882 A CY139882 A CY 139882A CY 1398 A CY1398 A CY 1398A
- Authority
- CY
- Cyprus
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- inflammatory agents
- steroidal anti
- containing non
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8126786 | 1981-09-04 | ||
| GB08225177A GB2105193B (en) | 1981-09-04 | 1982-09-03 | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1398A true CY1398A (en) | 1987-12-18 |
Family
ID=26280636
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY139882A CY1398A (en) | 1981-09-04 | 1982-09-03 | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents |
Country Status (2)
| Country | Link |
|---|---|
| CY (1) | CY1398A (en) |
| GB (1) | GB2105193B (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4636498A (en) * | 1984-10-11 | 1987-01-13 | Pfizer Inc. | Formulation of antiinflammatory drugs |
| US4567179A (en) * | 1984-10-11 | 1986-01-28 | Pfizer, Inc. | Antiinflammatory salts of piroxicam |
| US4757060A (en) * | 1986-03-04 | 1988-07-12 | Bristol-Myers Company | Non-steroidal anti-inflammatory compositions protected against gastrointestinal injury with a combination of certain H1 and H2, receptor blockers |
| IE58373B1 (en) * | 1986-06-18 | 1993-09-08 | Bloomfield Frederick Jacob | 5-Lipoxygenase pathway inhibitors |
| EP0320550A1 (en) * | 1987-12-18 | 1989-06-21 | Bristol-Myers Company | Non steroidal anti-inflammatory drug composition containing H1 blockers, H2 blockers, beta adrenergic agonists or combinations thereof and an alkalizing agent |
| EP0321613A1 (en) * | 1987-12-18 | 1989-06-28 | Bristol-Myers Company | The effect of a combination of a beta-adrenergic agonist and certain histamine H1- and/or H2-receptor blockers on gastrointestinal injury produced by nonsteroidal anti-inflammatory compositions |
| GB8805268D0 (en) * | 1988-03-04 | 1988-04-07 | Glaxo Group Ltd | Medicaments |
| GB8816187D0 (en) * | 1988-07-07 | 1988-08-10 | Glaxo Group Ltd | Medicaments |
| US5071842A (en) * | 1988-10-14 | 1991-12-10 | Bristol-Myers Squibb Company | Aspirin-containing composition including diphenhydramine and an alkalizing agent to reduce gastrointestinal injury potential |
| IN171746B (en) * | 1989-11-02 | 1992-12-26 | Mcneil Ppc Inc | |
| US5204118A (en) * | 1989-11-02 | 1993-04-20 | Mcneil-Ppc, Inc. | Pharmaceutical compositions and methods for treating the symptoms of overindulgence |
| ES2130152T3 (en) * | 1991-12-06 | 1999-07-01 | Glaxo Group Ltd | MEDICINES TO TREAT INFLAMMATORY PAIN OR ANALGESIA CONTAINING A NSAID AND RANITIDINE / BISMUTE CITRATE. |
| CA2144155A1 (en) * | 1992-09-29 | 1994-04-14 | Robert T. Sims | Ibuprofen-h2 antagonist combinations |
| HU213101B (en) * | 1992-12-29 | 1997-02-28 | Richter Gedeon Vegyeszet | Process for producing pharmaceutical composition of synergetic gastrocitoprotective activity, containing ranitidine and derivative of the salicylic acid |
| US7799766B2 (en) | 1998-04-08 | 2010-09-21 | Theta Biomedical Consulting & Development Co., Inc. | Composition for treating hormonally-dependent cancers |
| US20050220909A1 (en) | 2004-03-30 | 2005-10-06 | Theoharides Theoharis C | Composition for protection against superficial vasodilator flush syndrome |
| US7906153B2 (en) | 1998-04-08 | 2011-03-15 | Theta Biomedical Consulting & Development Co., Inc. | Anti-inflammatory compositions for treating multiple sclerosis |
| SE0000774D0 (en) | 2000-03-08 | 2000-03-08 | Astrazeneca Ab | New formulation |
| US8206741B2 (en) | 2001-06-01 | 2012-06-26 | Pozen Inc. | Pharmaceutical compositions for the coordinated delivery of NSAIDs |
| PT1411900E (en) | 2001-06-01 | 2010-10-11 | Pozen Inc | Pharmaceutical compositions for the coordinated delivery of nsaids |
| SE0102993D0 (en) | 2001-09-07 | 2001-09-07 | Astrazeneca Ab | New self emulsifying drug delivery system |
| US7923043B2 (en) | 2004-03-30 | 2011-04-12 | Theta Biomedical Consulting & Development Co., Inc. | Method for protecting humans against superficial vasodilator flush syndrome |
| US8067451B2 (en) | 2006-07-18 | 2011-11-29 | Horizon Pharma Usa, Inc. | Methods and medicaments for administration of ibuprofen |
| US8067033B2 (en) | 2007-11-30 | 2011-11-29 | Horizon Pharma Usa, Inc. | Stable compositions of famotidine and ibuprofen |
| AU2009290712A1 (en) | 2008-09-09 | 2010-03-18 | Astrazeneca Ab | Method for delivering a pharmaceutical composition to patient in need thereof |
| CA2764963C (en) | 2009-06-25 | 2016-11-01 | Astrazeneca Ab | Method for treating a patient at risk for developing an nsaid-associated ulcer |
| US9176146B2 (en) | 2009-08-03 | 2015-11-03 | Theta Biomedical Consulting & Development Co., Inc. | Methods of treating autism spectrum disorders and compositions for same |
| US9050275B2 (en) | 2009-08-03 | 2015-06-09 | Theta Biomedical Consulting & Development Co., Inc. | Methods of screening for and treating autism spectrum disorders and compositions for same |
| UA115139C2 (en) | 2011-12-28 | 2017-09-25 | Поузен Інк. | Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid |
-
1982
- 1982-09-03 GB GB08225177A patent/GB2105193B/en not_active Expired
- 1982-09-03 CY CY139882A patent/CY1398A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB2105193A (en) | 1983-03-23 |
| GB2105193B (en) | 1984-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2105193B (en) | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents | |
| GB2098865B (en) | Topical pharmaceutical compositions | |
| GB8519256D0 (en) | Analgesic/anti-inflammatory compositions | |
| GB8326565D0 (en) | Pharmaceutical compositions | |
| GB8327612D0 (en) | Pharmaceutical compositions | |
| GB8521793D0 (en) | Analgesic & anti-inflammatory compositions | |
| DE3367849D1 (en) | Pharmaceutical compositions containing n-substituted-3-hydroxypyrid-2-one or -4-one derivatives | |
| ZA824622B (en) | Pharmaceutical compositions | |
| GB2103090B (en) | Pharmaceutical compositions of non-steroidal anti-inflammatory agents | |
| ZA822856B (en) | Pharmaceutical compositions | |
| GB8308056D0 (en) | Pharmaceutical compositions | |
| GB2117766B (en) | Pharmaceutical compositions | |
| ZA82652B (en) | Pharmaceutical compositions | |
| GB8429749D0 (en) | Pharmaceutical compositions | |
| GB8313814D0 (en) | Pharmaceutical compositions | |
| GB2105588B (en) | Pharmaceutical compositions containing non-steroidal anti-inflammatory agents | |
| DE3377696D1 (en) | Pharmaceutical compositions | |
| GB2114001B (en) | Nasel pharmaceutical compositions | |
| GB2110930B (en) | Pharmaceutical compositions containing propionhydroxamic acid | |
| SG59387G (en) | Pharmaceutical compositions | |
| GB2110536B (en) | Pharmaceutical compositions containing pantetheine-s-sulphonic acid | |
| GB8305028D0 (en) | Pharmaceutical compositions | |
| GB8330810D0 (en) | Pharmaceutical compositions | |
| GB8314736D0 (en) | Pharmaceutical compositions | |
| DE3264222D1 (en) | New pharmaceutical compositions containing guanidinopyrimidines |